drugset / Trial / NCT01955759

Atrial Fibrillation and By-pass Surgery

NCT01955759

Phase 0 Unknown 260 enrolled Heart Center BH Tuzla
RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of the study is to evaluate whether combined therapy with beta-blocker, amiodarone and statine is better than beta-blocker alone for the prevention of atrial fibrillation after coronary by-pass surgery.

Timeline

Start
2013-12
Primary completion
2014-12
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiodarone Small molecule 200 mg Oral
Subject Rosuvastatin Small molecule 20 mg
Background Bisoprolol Other / unclassified

Indications

No indication recorded.